Literature DB >> 8700509

The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21.

M A Brown1, C F Xu, H Nicolai, B Griffiths, J A Chambers, D Black, E Solomon.   

Abstract

To begin to address the hypothesis that abnormal regulation of the breast/ovarian cancer susceptibility gene BRCA1 is a critical step in sporadic breast/ovarian tumorigenesis, we have determined the detailed structure of the BRCA1 genomic region. We show that this region of the genome contains a tandem duplication of approximately 30 kilobases, which results in two copies of BRCA1 exons 1 and 2, of exons 1 and 3 of the adjacent 1A1-3B gene and of the previously reported 295 base pair intergenic region. Sequence analysis of the duplicated exons of BRCA1 and 1A1-3B and flanking genomic DNA reveals maintenance of the intron-exon structure and a high degree of nucleotide sequence identity, suggesting that these are non-processed pseudogenes and that the duplication is a recent event in evolutionary terms. We also show that a processed pseudogene of the acidic ribosomal phosphoprotein P1 (ARPP1) is inserted directly upstream of pseudo-BRCA1 exon 1A. We believe that these findings could not only confound BRCA1 mutation analysis, but could have implications for the normal and abnormal regulation of BRCA1 transcription, translation and function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700509

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

Review 1.  Expression of BRCA1 and BRCA2 in normal and neoplastic cells.

Authors:  L A Chodosh
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

2.  Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

Authors:  X Liu; D F Barker
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

3.  Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

Authors:  Nadine Puget; Sophie Gad; Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Am J Hum Genet       Date:  2002-03-05       Impact factor: 11.025

4.  Dealing with Pseudogenes in Molecular Diagnostics in the Next Generation Sequencing Era.

Authors:  Kathleen B M Claes; Toon Rosseel; Kim De Leeneer
Journal:  Methods Mol Biol       Date:  2021

5.  Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

Authors:  M A Unger; K L Nathanson; K Calzone; D Antin-Ozerkis; H A Shih; A M Martin; G M Lenoir; S Mazoyer; B L Weber
Journal:  Am J Hum Genet       Date:  2000-09-07       Impact factor: 11.025

6.  Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin.

Authors:  A M Schulte; A Wellstein
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Regulation of BRCA1 transcription by specific single-stranded DNA binding factors.

Authors:  Sanjay Thakur; Tatsuya Nakamura; George Calin; Andrea Russo; Joseph F Tamburrino; Masayoshi Shimizu; Gustavo Baldassarre; Sabrina Battista; Alfredo Fusco; Richard P Wassell; Garret Dubois; Hansjuerg Alder; Carlo M Croce
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene.

Authors:  Sue Mei Tan-Wong; Juliet D French; Nicholas J Proudfoot; Melissa A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-28       Impact factor: 11.205

Review 9.  BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.

Authors:  Roshni D Kalachand; Britta Stordal; Stephen Madden; Benjamin Chandler; Julie Cunningham; Ellen L Goode; Ilary Ruscito; Elena I Braicu; Jalid Sehouli; Atanas Ignatov; Herbert Yu; Dionyssios Katsaros; Gordon B Mills; Karen H Lu; Mark S Carey; Kirsten M Timms; Jolanta Kupryjanczyk; Iwona K Rzepecka; Agnieszka Podgorska; Jessica N McAlpine; Elizabeth M Swisher; Sarah S Bernards; Ciaran O'Riain; Sharon O'Toole; John J O'Leary; David D Bowtell; David M Thomas; Katharina Prieske; Simon A Joosse; Linn Woelber; Parvesh Chaudhry; Norman Häfner; Ingo B Runnebaum; Bryan T Hennessy
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

10.  Functional Impact of Sequence Alterations Found in BRCA1 Promoter/5'UTR Region in Breast/Ovarian Cancer Families from Upper Silesia, Poland.

Authors:  Jolanta Pamuła; Małgorzata Krześniak; Helena Zientek; Wioletta Pekala; Marek Rusin; Ewa Grzybowska
Journal:  Hered Cancer Clin Pract       Date:  2006-01-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.